Abivax
ABVX
Source: the SEC Form 13F filings of the managers we follow, latest for Q2 2026. How we use them
Value held
$5.3m
Combined value at quarter end
Last quarter
1 bought
0 sold or trimmed
Managers holding it, by quarter
0Q4 ’23
0Q1 ’24
0Q2 ’24
0Q3 ’24
0Q4 ’24
0Q1 ’25
0Q2 ’25
0Q3 ’25
0Q4 ’25
0Q1 ’26
1Q2 ’26
0Q3 ’26
Who holds it
| Maverick Capital | 0.1%$5.3m | New |
About the company
- Sector
- Health care · Pharmaceutical Preparations
- Financial year ends
- 31 December
- SEC filings
- Annual reports and other filings on EDGAR